PON1 and metabolic dysfunction-associated steatotic liver disease: Therefore, we aimed to determine, via meta-analyses, whether or not the PON1 activity in NAFLD was low in order to confirm the importance of PON1 measurements as a co-adjuvant in the diagnosis and prognosis of NAFLD.